The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as adjuvant therapy in ctDNA-positive gastric and esophagogastric junction adenocarcinoma: A protocol for a randomized, controlled, multicenter phase Ⅱ clinical trial—EXPLORING study.
 
Yizhang Chen
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Fen Guo
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Jiaguang Zhang
No Relationships to Disclose
 
Xinyi Zhang
No Relationships to Disclose
 
Yitong Tian
No Relationships to Disclose
 
Lanlan Pan
No Relationships to Disclose
 
Ling Ma
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Xiaofeng Chen
No Relationships to Disclose